[시장보고서]암 악액질 시장 : 세계 업계 분석, 규모, 점유율, 성장, 동향, 예측(2023-2031년)

암 악액질 시장 : 세계 업계 분석, 규모, 점유율, 성장, 동향, 예측(2023-2031년)

Cancer Cachexia Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2031

상품코드 : 1420923

리서치사 : Transparency Market Research

발행일 : 2023년 12월

페이지 정보 : 영문 218 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,795

￦ 8,372,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,795

￦ 12,707,000

PDF (Multi-user License)

PDF 보고서를 동일 부서 5명이 이용할 수 있는 라이선스입니다. 텍스트 등의 Copy & Paste가 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 11,795

￦ 17,041,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

샘플 요청 목록에 추가

암 악액질 시장 - 보고서 범위

세계의 암 악액질 시장에 관한 TMR의 보고서는 과거와 현재의 성장 동향 및 2023년부터 2031년까지의 예측기간 동안 시장 지표의 귀중한 인사이트를 얻을 수 있는 기회를 연구하고 있습니다. 2023년을 기준 연도, 2031년을 예측 연도로 삼아 2017년부터 2031년까지의 세계 시장 매출을 제공합니다. 또한 2023년부터 2031년까지 연평균 성장률(CAGR %)도 제공합니다.

이 보고서는 광범위한 조사를 통해 작성되었습니다. 1차 조사에서는 조사 활동의 대부분이 이루어지고, 애널리스트가 주요 오피니언 리더, 업계 리더, 오피니언 메이커와의 인터뷰를 실시했습니다. 2차 조사에는 암 악액질 시장을 이해하기 위해 주요 기업의 제품 문헌, 연차 보고서, 프레스 릴리스 및 관련 문서에 대한 참조가 포함됩니다.

시장 현황
2023년 시장 가치	22억 달러
2031년 시장 가치	36억 달러
CAGR	4.7%

이 보고서는 세계의 암 악액질 시장 경쟁 상황을 자세히 살펴봅니다. 세계의 암 악액질 시장에서 활동하는 주요 기업이 확인되었으며, 이들 각각이 다양한 속성의 관점에서 프로파일링됩니다. 기업 개요, 재무 상황, 최근의 동향, SWOT는 이 보고서에서 소개되고 있는 세계의 암 악액질 시장 기업의 속성입니다.

시장 기업 - 경쟁 매트릭스(기업 계층 및 규모별)
시장 점유율 분석 : 기업별(2022년)
기업 개요
- Aeterna Zentaris, Inc.
- Alder BioPharmaceuticals Inc.
- Aphios Corporation
- Eli Lilly and Company
- GTx Inc.
- Helsinn Group
- Merck &Co. Inc.
- Novartis AG
- Bristol-Myers Squibb Company
- XBiotech, Inc.

KSM

영문 목차

영문목차

Cancer Cachexia Market - Scope of Report

TMR's report on the global cancer cachexia market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global cancer cachexia market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global cancer cachexia market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the cancer cachexia market.

Market Snapshot
Market Value in 2023	US$ 2.2 Bn
Market Value in 2031	US$ 3.6 Bn
CAGR	4.7%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global cancer cachexia market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global cancer cachexia market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global cancer cachexia market.

The report delves into the competitive landscape of the global cancer cachexia market. Key players operating in the global cancer cachexia market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global cancer cachexia market profiled in this report.

Key Questions Answered in Global cancer cachexia Market Report:

What is the sales/revenue generated by cancer cachexia across all regions during the forecast period?
What are the opportunities in the global cancer cachexia market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2031?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?

Cancer Cachexia Market - Research Objectives and Research Approach

The comprehensive report on the global cancer cachexia market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global cancer cachexia market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global cancer cachexia market.

1. Preface

1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Cancer Cachexia Market

4. Market Overview

4.1. Introduction
- 4.1.1. Product Definition
- 4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
4.4. Global Cancer Cachexia Market Analysis and Forecast, 2023-2031

5. Key Insights

5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry

6. Global Cancer Cachexia Market Analysis and Forecast, by Therapeutics

6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Therapeutics, 2023-2031
- 6.3.1. Progestogens
- 6.3.2. Corticosteroids
- 6.3.3. Combination Therapies
- 6.3.4. Others
6.4. Market Attractiveness Analysis, by Therapeutics

7. Global Cancer Cachexia Market Analysis and Forecast, by Mechanism of Action

7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Mechanism of Action, 2023-2031
- 7.3.1. Appetite Stimulators
- 7.3.2. Weight Loss Stabilizers
- 7.3.3. Others
7.4. Market Attractiveness Analysis, by Mechanism of Action

8. Global Cancer Cachexia Market Analysis and Forecast, by Distribution Channel

8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Distribution Channel, 2023-2031
- 8.3.1. Hospital Stores
- 8.3.2. Retail Pharmacy Stores
- 8.3.3. Online Pharmacies
8.4. Market Attractiveness Analysis, by Mechanism of Action

9. Global Cancer Cachexia Market Analysis and Forecast, by Region

9.1. Key Findings
9.2. Market Value Forecast, by Region, 2023-2031
- 9.2.1. North America
- 9.2.2. Europe
- 9.2.3. Asia Pacific
- 9.2.4. Latin America
- 9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region

10. North America Cancer Cachexia Market Analysis and Forecast

10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Therapeutics, 2023-2031
- 10.3.1. Progestogens
- 10.3.2. Corticosteroids
- 10.3.3. Combination Therapies
- 10.3.4. Others
10.4. Market Value Forecast, by Mechanism of Action, 2023-2031
- 10.4.1. Appetite Stimulators
- 10.4.2. Weight Loss Stabilizers
- 10.4.3. Others
10.5. Market Value Forecast, by Distribution Channel, 2023-2031
- 10.5.1. Hospital Stores
- 10.5.2. Retail Pharmacy Stores
- 10.5.3. Online Pharmacies
10.6. Market Value Forecast, by Country, 2023-2031
- 10.6.1. U.S.
- 10.6.2. Canada
10.7. Market Attractiveness Analysis
- 10.7.1. By Therapeutics
- 10.7.2. By Mechanism of Action
- 10.7.3. By Distribution Channel
- 10.7.4. By Country

11. Europe Cancer Cachexia Market Analysis and Forecast

11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Therapeutics, 2023-2031
- 11.3.1. Progestogens
- 11.3.2. Corticosteroids
- 11.3.3. Combination Therapies
- 11.3.4. Others
11.4. Market Value Forecast, by Mechanism of Action, 2023-2031
- 11.4.1. Appetite Stimulators
- 11.4.2. Weight Loss Stabilizers
- 11.4.3. Others
11.5. Market Value Forecast, by Distribution Channel, 2023-2031
- 11.5.1. Hospital Stores
- 11.5.2. Retail Pharmacy Stores
- 11.5.3. Online Pharmacies
11.6. Market Value Forecast, by Country/Sub-region, 2023-2031
- 11.6.1. Germany
- 11.6.2. U.K.
- 11.6.3. France
- 11.6.4. Italy
- 11.6.5. Spain
- 11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
- 11.7.1. By Therapeutics
- 11.7.2. By Mechanism of Action
- 11.7.3. By Distribution Channel
- 11.7.4. By Country/Sub-region

12. Asia Pacific Cancer Cachexia Market Analysis and Forecast

12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Therapeutics, 2023-2031
- 12.3.1. Progestogens
- 12.3.2. Corticosteroids
- 12.3.3. Combination Therapies
- 12.3.4. Others
12.4. Market Value Forecast, by Mechanism of Action, 2023-2031
- 12.4.1. Appetite Stimulators
- 12.4.2. Weight Loss Stabilizers
- 12.4.3. Others
12.5. Market Value Forecast, by Distribution Channel, 2023-2031
- 12.5.1. Hospital Stores
- 12.5.2. Retail Pharmacy Stores
- 12.5.3. Online Pharmacies
12.6. Market Value Forecast, by Country/Sub-region, 2023-2031
- 12.6.1. China
- 12.6.2. Japan
- 12.6.3. India
- 12.6.4. Australia & New Zealand
- 12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
- 12.7.1. By Therapeutics
- 12.7.2. By Mechanism of Action
- 12.7.3. By Distribution Channel
- 12.7.4. By Country/Sub-region

13. Latin America Cancer Cachexia Market Analysis and Forecast

13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Therapeutics, 2023-2031
- 13.3.1. Progestogens
- 13.3.2. Corticosteroids
- 13.3.3. Combination Therapies
- 13.3.4. Others
13.4. Market Value Forecast, by Mechanism of Action, 2023-2031
- 13.4.1. Appetite Stimulators
- 13.4.2. Weight Loss Stabilizers
- 13.4.3. Others
13.5. Market Value Forecast, by Distribution Channel, 2023-2031
- 13.5.1. Hospital Stores
- 13.5.2. Retail Pharmacy Stores
- 13.5.3. Online Pharmacies
13.6. Market Value Forecast, by Country/Sub-region, 2023-2031
- 13.6.1. Brazil
- 13.6.2. Mexico
- 13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
- 13.7.1. By Therapeutics
- 13.7.2. By Mechanism of Action
- 13.7.3. By Distribution Channel
- 13.7.4. By Country/Sub-region

14. Middle East & Africa Cancer Cachexia Market Analysis and Forecast

14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Therapeutics, 2023-2031
- 14.3.1. Progestogens
- 14.3.2. Corticosteroids
- 14.3.3. Combination Therapies
- 14.3.4. Others
14.4. Market Value Forecast, by Mechanism of Action, 2023-2031
- 14.4.1. Appetite Stimulators
- 14.4.2. Weight Loss Stabilizers
- 14.4.3. Others
14.5. Market Value Forecast, by Distribution Channel, 2023-2031
- 14.5.1. Hospital Stores
- 14.5.2. Retail Pharmacy Stores
- 14.5.3. Online Pharmacies
14.6. Market Value Forecast, by Country/Sub-region, 2023-2031
- 14.6.1. GCC Countries
- 14.6.2. South Africa
- 14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
- 14.7.1. By Therapeutics
- 14.7.2. By Mechanism of Action
- 14.7.3. By Distribution Channel
- 14.7.4. By Country/Sub-region

15. Competition Landscape

15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
- 15.3.1. Aeterna Zentaris, Inc.
  - 15.3.1.1. Company Overview
  - 15.3.1.2. Product Portfolio
  - 15.3.1.3. SWOT Analysis
  - 15.3.1.4. Financial Overview
  - 15.3.1.5. Strategic Overview
- 15.3.2. Alder BioPharmaceuticals Inc.
  - 15.3.2.1. Company Overview
  - 15.3.2.2. Product Portfolio
  - 15.3.2.3. SWOT Analysis
  - 15.3.2.4. Financial Overview
  - 15.3.2.5. Strategic Overview
- 15.3.3. Aphios Corporation
  - 15.3.3.1. Company Overview
  - 15.3.3.2. Product Portfolio
  - 15.3.3.3. SWOT Analysis
  - 15.3.3.4. Financial Overview
  - 15.3.3.5. Strategic Overview
- 15.3.4. Eli Lilly and Company
  - 15.3.4.1. Company Overview
  - 15.3.4.2. Product Portfolio
  - 15.3.4.3. SWOT Analysis
  - 15.3.4.4. Financial Overview
  - 15.3.4.5. Strategic Overview
- 15.3.5. GTx Inc.
  - 15.3.5.1. Company Overview
  - 15.3.5.2. Product Portfolio
  - 15.3.5.3. SWOT Analysis
  - 15.3.5.4. Financial Overview
  - 15.3.5.5. Strategic Overview
- 15.3.6. Helsinn Group
  - 15.3.6.1. Company Overview
  - 15.3.6.2. Product Portfolio
  - 15.3.6.3. SWOT Analysis
  - 15.3.6.4. Financial Overview
  - 15.3.6.5. Strategic Overview
- 15.3.7. Merck & Co. Inc.
  - 15.3.7.1. Company Overview
  - 15.3.7.2. Product Portfolio
  - 15.3.7.3. SWOT Analysis
  - 15.3.7.4. Financial Overview
  - 15.3.7.5. Strategic Overview
- 15.3.8. Novartis AG
  - 15.3.8.1. Company Overview
  - 15.3.8.2. Product Portfolio
  - 15.3.8.3. SWOT Analysis
  - 15.3.8.4. Financial Overview
  - 15.3.8.5. Strategic Overview
- 15.3.9. Bristol-Myers Squibb Company
  - 15.3.9.1. Company Overview
  - 15.3.9.2. Product Portfolio
  - 15.3.9.3. SWOT Analysis
  - 15.3.9.4. Financial Overview
  - 15.3.9.5. Strategic Overview
- 15.3.10. XBiotech, Inc.
  - 15.3.10.1. Company Overview
  - 15.3.10.2. Product Portfolio
  - 15.3.10.3. SWOT Analysis
  - 15.3.10.4. Financial Overview
  - 15.3.10.5. Strategic Overview

한글목차

암 악액질 시장 - 보고서 범위

목차

제1장 서문

제2장 가정과 조사 방법

제3장 주요 요약 : 세계 시장

제4장 시장 개요

제5장 중요한 인사이트

제6장 세계 시장 분석과 예측 : 요법별

제7장 세계 시장 분석과 예측 : 작용기서별

제8장 세계 시장 분석과 예측 : 유통 채널별

제9장 세계 시장 분석과 예측 : 지역별

제10장 북미 시장 분석과 예측

제11장 유럽 시장 분석과 예측

제12장 아시아태평양 시장 분석과 예측

제13장 라틴아메리카 시장 분석과 예측

제14장 중동 및 아프리카 시장 분석과 예측

제15장 경쟁 상황